Intervention

Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

1 shown

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerNCT01067989 · 2010-03-01

TERMINATED

Common conditions

Breast Cancer, Metastatic1 Chemotherapy1

Leading sponsors

HaEmek Medical Center, Israel1

Trial status mix

TERMINATED1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.